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Background: According to the ‘‘immune-editing” theory,
immunocompetent cells being important component of the
tumor microenvironment can both show antitumor activity and
contribute to the tumor progression. Tumor pathophysiological
features affect the structural and functional changes of certain
components of tumor microenvironment, in particular, increase
the number of T-lymphocytes with regulatory activity (Treg).
FOXP3, transcription factor, acts as master regulator for
suppressive function of Treg. Recent studies have shown FOXP3
is expressed both in immunocompetent cells and tumor cells;
however, the function of this gene in malignant tumors of
different genesis is ambiguous (GirdhariLal, et al., 2014). The
aim of the study was quantitative assessment of subpopulations
CD4+, CD8+, FOXP3+-lymphocytes associated with the tumor,
FOXP3+-tumor cells and comparison of these parameters with
the clinical and morphological characteristics of endometrial
cancer (EC).
Materials and methods: A total of 40 EC patients who did not
receive special treatment before surgery with the mean age
56.9 ± 2.8 years were included in the study. Morphological and
immunohistochemical methods were used in the study (primary
monoclonal antibodies: CD4 – clone 4B12, ‘‘Millipore”, USA,
CD8 – clone RIV – 11, ‘‘Millipore”, USA, FOXP3 – clone 5H5L12,
‘‘Invitrogen”, USA, Ki-67 - clone MIB1, ‘‘DakoCytomation”,
Denmark) and Real-Time PCR was also used to determine the
DNA methylation status of FOXP3 gene mathematical statistics.
Results: The dependence of the number of intratumoral CD4+-,
CD8+- lymphocytes and FOXP3-lymphocytes on such biological
characteristics as the degree of differentiation, growth rate and
depth of invasion into the myometrium was established. In
endometrial adenocarcinomas, low grade content of FOXP3+ lym-
phocytes increased (27.8 ± 2.6%), number of intratumoral CD4+
(15,3 ± 0,2%), CD8+-lymphocytes (29.6 ± 0.3%) and FOXP3+-tumor
cells (15,5 ± 3,3%) decreased in contrast to the same parameters
in high grade tumors: FOXP3+-lymphocytes (17.4 ± 3.0%),
CD4+ (52.0 ± 2.7%), CD8+ (46.4 ± 5.6%), FOXP3+-tumor cells
(27.8 ± 2.6%), p < 0.05. DNA analysis of endometrial tumor
showed that FOXP3 gene promoter was methylated in 71% of
cases. The number of cases with positive methylation status
was increasing with lower differentiation grade, that was associ-
ated with the low number of FOXP3+-tumor cells. Statistically sig-
nificant correlation (p < 0.05) (Spearman rank correlation) was
observed between the deep invasion of tumor in myometrium
and the number of FOXP3+-tumor cells (R = 0.63), number of
FOXP3+- and CD4+-lymphocytes (R = 0.68 andR = 0.55, respec-
tively) as well as the level of tumor proliferative activity
(R = 0.74).
Conclusion: Quantitative changes of some components of the
tumor microenvironment such as CD4+-, CD8+-, FOXP3+-
lymphocytes and content of FOXP3+-tumor cells correlate with
the biological characteristics of EC and apparently have a
significant role in the progression of this cancer.
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Background: The aim of the study was to identify the factors
that determine outcome and overall survival of HNC patients of
Tomsk region.
Materials and methods: Clinical data, morphological charac-
teristics of tumors and outcomes were obtained for 91 patients.
Data about lifestyle, food preferences, smoking history were
obtained from the questionnaire (n = 35). All clinical samples
were tested by AmpliSens HPV diagnostic kits (Russia) to deter-
mine prevalence of 12 high risk HPV types. Statistical analysis
was performed using Kaplan–Meier method, Cox regression,
Gehan test, Fisher test, Mann–Whitney and Kruskal–Wallis tests.
Results: Gender, age, smoking status, alcohol consumption,
distance from harmful factors, professional hazards and duration
of its exposure as well as tumor criteria such as T, N, G, the pres-
ence of keratinization, invasion into the underlying tissues, HPV-
infection, chemotherapy and/or radiation therapy and response
to the treatment were assessed for HNC patients. It was shown
that the two-year survival rate was about 70%, and the five-year
survival rate was about 32%. There was strong correlation
between decreased overall survival and increased alcohol con-
sumption (p = 0.03) as well as regional lymph nodes status
(p = 0.01). Patients with early tumor stages and N0 lymph node
status as well as patients receiving chemotherapy and/or radio-
therapy showed trend towards to better survival (p = 0.09,
p = 0.1, p = 0.09, respectively). Overall survival of patients with
lymph node metastasis was higher in case of early tumor stages
(p = 0.08) and in patients who had no alcohol consumption history
(p = 0.06). Cox regression analysis was used to obtain the model
describing overall survival of patients. The model with the high-
est level of significance includes 3 factors-nodal metastases, the
presence of keratinization and radiotherapy. It was shown that
the risk of death was 4.2 and 2.6-fold higher in case of lymph
node metastases and keratinized cancer, and 2.7-fold lower in
case of radiotherapy. It was also shown that metastasis occurred
more frequently in cases with invasion into the underlying tissue
of a primary tumor (p = 0.04) and in cases with a low tissue grade
(p = 0.02). Association of alcohol consumption with questionnaire
data was studied. It was shown that men’s preferably smokers
consume alcohol more often than other patients (p = 0.006,
p = 0.02, respectively). Our data showed that HPV prevalence
was higher in smokers (p = 0.04), and in patients with early tumor
stages (p = 0.07). Furthermore, response to radiotherapy was
better in HPV-positive patients compared to HPV-negative cases
(p = 0.09). Better response to radiotherapy showed the group of
patients who received dose higher than 45 Gy (p = 0.03) and who
had no lymph node metastases(p = 0.05).
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Conclusion: Our data showed that metastasis to lymph nodes
and alcohol consumption are the main factors that affect mortal-
ity in HNC patients of Tomsk region.
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Background: Risk of metastasis formation is provided by both
tumor cell biological characteristics and the microenvironment
features within the primary tumor along with local and systemic
conditions for metastatic niche formation. The inflammatory
infiltration has been shown to strongly impact on tumor progres-
sion (Whiteside, 2013). Dronca et al. (2011) showed that immuno-
suppressive factors in the tumor microenvironment may impair
not only local immune responses but also disturb systemic
immunity. Zitvogel et al. anticipate that the comprehension of
the mechanisms governing the immunogenicity of cell death will
have a profound impact on the design of anticancer therapies.To
study the impact of immune system on clinical response to
neoadjuvant chemotherapy and metastasis-free survival in
breast cancer patients.
Materials and methods: 350 patients with newly diagnosed
invasive breast cancer treated with neoadjuvant chemotherapy
(NAC) were enrolled into the study. The procedures were made
in accordance with the Helsinki Declaration. Clinical response
to chemotherapy, the 5-year metastasis-free survival and all
major clinical and morphological parameters were determined.
The original method of multidimensional data visualization was
applied to present the immune system state as integral entirety
in visual image for classification of patients with different risk
of metastasis (NovoSpark Corporation, Canada). Copy number
aberrations (CNA) of cytokine gene regions in tumor specimens
were tested using high-density microarray platform CytoScanTM
HD Array (Affymetrix, USA). Cytokine gene polymorphism was
analyzed. Subpopulations of lymphocytes and macrophages were
determined within the primary tumors by IHC.
Results: We found, that favorable clinical immediate response
to preoperative chemotherapy was related to the high levels of
IL-1beta, TNF-alpha and IL-10 production by peripheral mononu-
clear cells before the treatment. This correlation was further con-
firmed by data from the study on association between cytokine
gene functional polymorphism and response to NAC. We used
NovoSpark Corporation visualization approach allowing the
representation the immune system state as integral unit and to
discriminate breast cancer patients with high and low risk of
haematogeneic metastasis. When estimated before cancer treat-
ment, 95% of breast cancer patients had risk of metastasis. The
neoadjuvant chemotherapy and surgical tumor removal reduced
the risk of tumor progression to 62–71%. However, in a year after
adjuvant chemo- and radiotherapy, the patient group with high
risk of metastases increased to 81% again. Thus, the cancer treat-
ment can change the primarily estimated outcome prognosis in
breast cancer patients, and the monitoring of immune system
is a promising approach to predict the risk of cancer progression
or resistance to the therapy. We have found the connection
between the profile of intra-tumor inflammatory elements and
chemotherapy efficacy.Cytokine gene expression may be influ-
enced by the chromosome anomalies (CNA – Copy Number
Aberration) – deletion and amplification – of cytokine gene loci
in tumor cells. We found the close relation between the clinical
response to NAC and gain of function of IL-10 and CHI3L1
(YKL40) genes. In contrast, loss of TNF-alpha and IL-17 gene
function due to corresponding CNA was associated with good
response to NAC. Metastasis-free survival of breast cancer
patients was shown to be closely related to CNA.
Conclusion: The parameters of the activation of systemic and
intra-tumoral immune system by growing tumor and its dissem-
ination have to be validated in order to identify the new prognos-
tic markers for the efficiency of the neoadjuvant chemotherapy.
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The strong connection between cancer-related inflammation
and tumour development with pattern – recognizing receptors
(PRRs) activation results in identification of new target molecules
that could lead to improved cancer diagnosis and treatment.
TLR3, RIG1 and MDA5 synthetic ligand poly(I:C) was shown to
trigger apoptosis in cancer cells. However, TLR3 signaling also
includes NF-kB transcription factor which has emerged as
endogenous tumour promoter via stimulation of pro-
inflammatory tumour microenvironment, enhancement of
angiogenesis, tumour cell proliferation and metastasis. Thus
down regulation of NF-kB-mediated effects after TLR3 activation
is needed for implementation of TLR3 ligand-based therapy into
clinical trials.
We have earlier demonstrated that DNA and sequence specific
ODNs inhibit poly(I:C)-induced production of pro-inflammatory
cytokines in human primary fibroblasts and endothelial cells
(Cherepanova et al., Immunobiology, 2013). Using these specific
ODNs and affinity modification/isolation approach combined
with subsequent MALDI-TOF the main cellular targets for these
ODNs were identified as Ku protein – heterodimer of KU70 and
KU80 (Cherepanova et al., Exp. Opin. Biol. Ther., 2012).
The goals of this study are to reveal whether the ODNs target
poly(I:C)-induced activation in tumour cells: cervical carcinoma
(Hela) and epidermoid carcinoma (A431) and to confirm Ku
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